Read + Share
Al Rabadi LS, Cook MM, Kaempf AJ, Saraceni MM, et al. Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in
patients previously treated with Pertuzumab. BMC Cancer 2021;21:1150.
PMID: 34706686
|
 |
|
Al Rabadi LS, Cook MM, Kaempf AJ, Saraceni MM, et al. Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in
patients previously treated with Pertuzumab. BMC Cancer 2021;21:1150.
PMID: 34706686
|
|
|
|